Key facts
- Point72 Asset Management, L.P. filed SCHEDULE 13G for Forte Biosciences, Inc. Common Stock, par value $0.001 per share (FBRX).
- Disclosed ownership: 6.3%.
- Date of event: 12 Jan 2026.
Point72 Asset Management, L.P. - 12 Jan 2026 SCHEDULE 13G Report for Forte Biosciences, Inc. Common Stock, par value $0.001 per share (FBRX)
- Filing manager
- Point72 Asset Management, L.P.
- Reporting owner
- Point72 Asset Management, L.P.
- Symbol
- FBRX
- Shares outstanding
- 12,586,921 shares
- Disclosed ownership
- 792,976 shares
- Ownership
- 6.3%
- Form type
- SCHEDULE 13G
- Filing time
- 20 Jan 2026, 16:51:37 UTC
- Date of event
- 12 Jan 2026
- SEC
- View on sec.gov
Key filing fact
Point72 Asset Management, L.P. disclosed 6.3% ownership in Forte Biosciences, Inc. Common Stock, par value $0.001 per share (FBRX) on 12 Jan 2026.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 20 Jan 2026, 16:51.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 6.3% | 792,976 | 0 | 792,976 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 6.3% | 792,976 | 0 | 792,976 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 6.3% | 792,976 | 0 | 792,976 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |
CIK / CUSIP context first